Tricuspid Valve Fungal Endocarditis in a Patient with Breast Cancer and an Implantable Chemotherapy Venous Access Port

Petros Fountoulakis, Aikaterini Siama, Aimilianos Kalogeris, Marianthi Iliopoulou, Athanasios Tsoukas, Athanasios Manolis

Abstract


Fungal endocarditis, a rare and lethal infection, is aetiologically connected with Candida and Aspergillus species. Among these two agents, Candida is a common nosocomial infection with increasing rates over the last years and mortality up to 40% in cases of systemic candidiasis. In the present paper, we describe the case of a 58 year old woman with metastatic breast cancer under palliative chemotherapy who was hospitalized for recurrent episodes of fever due to fungal endocarditis of the implantable venous access port. Such cases may elude the attention of the physician and need to be taken into account especially in oncologic patients with implantable devices under chemotherapy regimens. The treatment of Candida endocarditis can be difficult because of the formation of biofilms on prosthetic devices. The prognosis of these patients may be ameliorated with the combination of fungal and invasive treatment.


Keywords


Cardiooncology; right sided infective endocarditis; fungal endocarditis; intraport catheter; breast cancer

Full Text:

Fountoulakis581

References


References

Yuan S-M. Right-sided infective endocarditis: recent epidemiologic changes. Int J Clin Exp Med. 2014 Jan 15;7(1):199–218.

Yuan S-M. Fungal Endocarditis. Braz J Cardiovasc Surg. 2016 Jun;31(3):252–255. doi:10.5935/1678-9741.20160026.

Simon MS, Somersan S, Singh HK, Hartman B, Wickes BL, Jenkins SG, et al. Endocarditis caused by Rhodotorula infection. J Clin Microbiol. 2014 Jan;52(1):374–378. doi:10.1128/JCM.01950-13.

Lebeaux D, Larroque B, Gellen-Dautremer J, Leflon-Guibout V, Dreyer C, Bialek S, et al. Clinical outcome after a totally implantable venous access port-related infection in cancer patients: a prospective study and review of the literature. Medicine. 2012 Nov;91(6):309–318. doi:10.1097/MD.0b013e318275ffe1.

Fernández-Cruz A, Muñoz P, Sandoval C, Fariñas C, Gutiérrez-Cuadra M, Pericás Pulido JM, et al. Infective endocarditis in patients with cancer: a consequence of invasive procedures or a harbinger of neoplasm?: A prospective, multicenter cohort. Medicine. 2017 Sep;96(38):e7913. doi:10.1097/MD.0000000000007913.

Pappas PG, Kauffman CA, Andes D, Benjamin DK, Calandra TF, Edwards JE, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009 Mar 1;48(5):503–535. doi:10.1086/596757.

Lejko Zupanc T, Logar M. Candida endocarditis: A review of twelve episodes in eleven patients. J Heart Valve Dis. 2017 Jan;26(1):98–102.

Reyes HA, Carbajal WH, Valdez LM, Lozada C. Successful medical treatment of infective endocarditis caused by Candida parapsilosis in an immunocompromised patient. BMJ Case Rep. 2015 Oct 9;2015. doi:10.1136/bcr-2015-212128.

Koumallos N, Paschalis A, Antoniades C, Tousoulis D, Simpsiris P, Tolios I, et al. Valve replacement for Brucella endocarditis: two case reports. Int J Cardiol. 2008 Jul 4;127(2):e83–5. doi:10.1016/j.ijcard.2007.04.081.

Arnold CJ, Johnson M, Bayer AS, Bradley S, Giannitsioti E, Miró JM, et al. Candida infective endocarditis: an observational cohort study with a focus on therapy. Antimicrob Agents Chemother. 2015 Apr;59(4):2365–2373. doi:10.1128/AAC.04867-14.

Shewan LG, Coats AJS, Henein MY. Authors’ Responsibilities and Ethical Publishing. International Cardiovascular Forum Journal 2018;13:3-4, doi: 10.17987/icfj.v13i0.525




DOI: https://doi.org/10.17987/icfj.v16i0.581

Copyright (c) 2019 Petros Fountoulakis, Aikaterini Siama, Aimilianos Kalogeris, Marianthi Iliopoulou, Athanasios Tsoukas, Athanasios Manolis

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.